Results 141 to 150 of about 36,008 (205)
Monoamine oxidase and xanthine oxidase inhibitors represent useful multi-target drugs for the prevention, attenuation, and treatment of oxidative damage and neurodegenerative disorders.
Antonio D’Errico +9 more
doaj +1 more source
Macià Buades-Rotger,1,2 David Gallardo-Pujol1,3 1Department of Personality, Faculty of Psychology, University of Barcelona, Barcelona, Spain; 2Department of Neurology, University of Lübeck, Lübeck, Germany; 3Institute for Brain ...
Buades-Rotger M, Gallardo-Pujol D
doaj
Hallucinogens: mechanisms and medical complications [PDF]
Thesis (M.A.)--Boston UniversityHallucinogens are drugs that alter consciousness by distorting primarily auditory and visual perception but they can affect any sensory system. Hallucinogens also affect judgment, orientation, memory, or emotion.
Chan, Ryan Harry Alexander
core +1 more source
Benzylisoquinoline Biosynthesis by Cultivated Plant Cells and Isolated Enzymes [PDF]
Amann, Manfred +4 more
core +1 more source
Histochemical Demonstration of Monoamine Oxidase in Human Skin1 [PDF]
Shelley, Walter B. +2 more
core +1 more source
Ultrasonic vocalizations as a predictor of resilience to intermittent swim stress-induced anxiety: An investigation of re-exposure effects [PDF]
Drugan, Robert C +2 more
core +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Furoxanobenzofuroxan, a selective monoamine oxidase inhibitor
Biochemical Pharmacology, 1974Abstract Furoxanobenzofuroxan (FBF) has been previously described as an inhibitor of monoamine oxidase. Inhibition was reversible, and of a mixed competitive and non-competitive type, with a molar inhibition constant of 4 × 10 −7 M. In vivo , the drug was selective in elevating the levels of indolealkylamines but not phenylethylamines. Low doses of
A G, Bolt, M J, Sleigh
openaire +2 more sources
Dietary inhibitors of monoamine oxidase A
Journal of Neural Transmission, 2010Inhibition of monoamine oxidase is one way to treat depression and anxiety. The information now available on the pharmacokinetics of flavonoids and of the components of tobacco prompted an exploration of whether a healthy diet (with or without smoking) provides active compounds in amounts sufficient to partially inhibit monoamine oxidase.
Sarah E, Dixon Clarke, Rona R, Ramsay
openaire +2 more sources

